Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


There's No Place Like the Home Health Care Market

This article was originally published in Start Up

Executive Summary

The market for home health care products, valued at $4.3 billion today, is one of the largest and most stable medtech markets in the US, according to "US Markets for Home Health Care Products," a report recently published by the FDC-Windhover division of Elsevier Business Intelligence. Like most health care markets, it owes its growth to the burgeoning aging population. This population will only grow. As the larger elderly segment of the population ages, they'll require care. But rising health care costs have forced patients to recover from disease and injury at home rather than in an acute care or even rehabilitation setting. A dangerous shortage of facilities, nurses and other skilled health care personnel adds to the pressures and ensures strong growth in the home health care market for the foreseeable future.

You may also be interested in...

Wound Care Devices: Growth Amid Uncertainty

Over the last 15 years, a trend toward evidence-based medicine has led to a greater understanding of the science behind wound healing. This knowledge has fueled an explosion of innovation in technology and in the commercialization of a wide range of new products, generating a worldwide market estimated at $4.5 billion annually, with double-digit growth projected over the next three to five years.

Once Sluggish Sleep Apnea Gets Active

The past year was a busy one in the sleep apnea sector of the respiratory market. All three major segments of the sleep apnea market--sleep testing equipment, continuous positive airway pressure (CPAP) devices, and therapeutic implants--were represented by the year's deals, which include four acquisitions and two venture financings, and we're not even counting the $4.9 billion acquisition of Respironics by Philips, which was announced at the tail end of 2007.

Philips Homes In on Respironics: Fills Gaps in Care Continuum

No company has done more to wrap its arms around the whole area of patient monitoring--both in and out of the hospital--than Philips Medical Systems. Since early 2006, Philips has made at least seven acquisitions that have helped it create the infrastructure for a telehealth approach to disease management, including monitoring equipment, IT, and emergency response services. To close out 2007, Philips announced an additional acquisition: a $5.1 billion all-cash offer for respiratory therapy provider Respironics, to buy the leading company in a universe of only three independent companies focused on obstructive sleep apnea, the fastest growing market in home health monitoring.

Related Content

Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts